FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Arm patents



      
           
This page is updated frequently with new Arm-related patent applications. Subscribe to the Arm RSS feed to automatically get the update: related Arm RSS feeds. RSS updates for this page: Arm RSS RSS


Device and method for the dynamic load management of cloud services

Device and method for the dynamic load management of cloud services

Remote notification system

Remote notification system

Remote notification system

Conditional monitoring of industrial systems

Date/App# patent app List of recent Arm-related patents
11/13/14
20140337867
 Method and system to confirm co-location of multiple devices within a geographic area patent thumbnailMethod and system to confirm co-location of multiple devices within a geographic area
A method and system to confirm co-location of multiple devices within a geographic area, while filtering spurious alarms, is provided. An example method comprises processing first gps data obtained from a first gps sensor and second gps data obtained from a second gps sensor.
11/13/14
20140337435
 Device and method for the dynamic load management of cloud services patent thumbnailDevice and method for the dynamic load management of cloud services
The invention substantially relates to a device and a method for the dynamic load management of cloud services. At least one cloud service can be used by a service client, and the service client has a load management adapter which exchanges messages comprising reservation feedback with a service load manager, said service load manager exchanging additional messages in the form of an execution plan with the cloud service.
11/13/14
20140337045
 Remote notification system patent thumbnailRemote notification system
A wireless remote notification system for use by a medical practitioner having a wireless capable tablet personal computer, to monitor each one of a group of patients in an infusion treatment center, the tablet personal computer wirelessly connects to and displays each patient's intravenous fluid pump output of treatment session time, intravenous fluid type, intravenous fluid conditions of gas content, fluid pressure, and flow-rate, including an alarm for abnormal intravenous fluid conditions. The tablet personal computer giving the medical practitioner an instant notice of a particular patient's abnormal intravenous fluid condition facilitating the medical practitioner the ability to quickly take corrective action and potentially deactivate the alarm quickly, thus reducing patient aggravation from their intravenous fluid condition alarms and adjacent patient intravenous fluid condition alarms..
11/13/14
20140336984
 Conditional monitoring of industrial systems patent thumbnailConditional monitoring of industrial systems
Performances of components of an industrial system are conditionally monitored as a function of key performance indicator data by defining baseline key performance indicator values for raw data obtained by data sensors from the operation of the components, and diagnostic rules to triggering alarms by comparing baseline key performance indicator values to thresholds. Generated alarms are stored in association with the historic raw diagnostic data, times of acquisition of the historic raw data and times of generation of the alarms.
11/13/14
20140336934
 Ensemble wind power forecasting platform system and operational method thereof patent thumbnailEnsemble wind power forecasting platform system and operational method thereof
The present invention relates to an ensemble wind power forecasting platform system and the operational method thereof. According to the present invention, a great amount of wind energy predictions from multiple sources, including numerical weather prediction information, multi-grid prediction information, and multiple wind-energy predicting methods, are integrated and processed for providing users with an ensemble prediction.
11/13/14
20140336746
 Modular stent graft patent thumbnailModular stent graft
The present invention relates to a modular stent graft which is designed for introduction into a blood vessel in a patient and which has a stent connected by means of a graft material; the stent graft has a first stent graft module having a body, a proximal end and a distal end, as well as at least three tubular arms extending longitudinally in the distal direction from the distal end of the first stent graft module, said arms being integrally connected to the body of the first stent graft module; in addition, a second stent graft module is provided which has a second body, a proximal end and a distal end, as well as at least three tubular arms extending longitudinally in the proximal direction from the proximal end of the second stent graft module, said arms being integrally formed with the body of the second stent graft module; in the assembled state a modular stent graft is formed, the modules of which are situated in the same blood vessel.. .
11/13/14
20140336683
 Hermetic occlusion surgical clamp for the cervix in cases of placenta previa patent thumbnailHermetic occlusion surgical clamp for the cervix in cases of placenta previa
The present invention relates to a hermetic occlusion surgical clamp for the female cervix to be used in case of placenta previa, including compression jaws with a spring (5.1) and semi-conical sections (5.2) and at the end of each jaw a machined semi-cylinder (5.3), and a pull-down cylinder with a machining that generated two arms (6.2) with a hole that is joined by a pin (5.4) that connects the jaws to the pull-down cylinder. The pull-down cylinder also includes a thread (6.4).
11/13/14
20140336647
 Skull clamp system with pressure limited and alarm systems patent thumbnailSkull clamp system with pressure limited and alarm systems
The skull clamp system with pressure limiting and alarm systems includes at least one and preferably multiple inwardly power driven immobilizing pins adjustably engaging the skull of a patient. The pin power drive systems includes at least one sensor capable of sensing the degree of back pressure on the pin from contact of the pin against the bone of the patient, the sensor being capable of signaling the drive system to stop when the sensor detects a preselected degree of back pressure.
11/13/14
20140336610
 Methods and devices for point of use mixing of pharmaceutical formulations patent thumbnailMethods and devices for point of use mixing of pharmaceutical formulations
Methods and devices for delivering variable amounts of a drug formulation directly from a drug delivery device without requiring point of use reconstitution as a separate mixing step are described herein. These methods and devices increase the convenience, speed and simplicity of administration of drug formulations.
11/13/14
20140336609
 Moisture barrier for clothing patent thumbnailMoisture barrier for clothing
A moisture barrier for clothing includes a pad having an upper layer made from a soft woven material, such as cotton, an intermediate absorbent layer, a moisture barrier layer, and an adhesive layer. The moisture barrier for clothing is oval in shape, accommodating its length and width, depending upon the user's needs.
11/13/14
20140336556
Posture support garment
Disclosed is a posture support garment. The posture support garment can be designed to use an elastic tension fabric that provides tension on the left sleeve and right sleeve of the posture support garment.
11/13/14
20140336471
Kit of parts for use in retracting body tissue
A retractor for use in spinal surgery comprises a frame including a ring member defining a generally central interior space. A plurality of blades is releasably supported respectively to slidable arms each supported on the ring member for individual translational movement relative to the ring member.
11/13/14
20140336468
Method of retracting body tissue during surgery
A retractor for use in spinal surgery comprises a frame including a ring member defining a generally central interior space. A plurality of blades is releasably supported respectively to slidable arms each supported on the ring member for individual translational movement relative to the ring member.
11/13/14
20140336412
Process for the preparation of gamma amino acids and intermediates used in said process
The invention relates to the preparation of gamma amino acids of formula (i) and pharmaceutically acceptable salts, solvates and prodrugs thereof, and to intermediates used for their preparation. (formula i) wherein r1 is selected from an alkyl group, an alkenyl group, an alkynyl group and a cycloalkyl group, each of which may be optionally substituted and * denotes a chiral centre.
11/13/14
20140336382
Tyrosine kinase inhibitors
The present disclosure provides compounds and pharmaceutically acceptable salts thereof that are tyrosine kinase inhibitors, in particular blk, bmx, egfr, her2, her4, itk, tec, btk, and txk and are therefore useful for the treatment of diseases treatable by inhibition of tyrosine kinases such as cancer and inflammatory diseases such as arthritis, and the like. Also provided are pharmaceutical compositions containing such compounds and pharmaceutically acceptable salts thereof and processes for preparing such compounds and pharmaceutically acceptable salts thereof..
11/13/14
20140336378
Novel benzamide derivative and use thereof
Disclosed are a novel benzamide derivative and pharmaceutical use thereof, and more particularly, a novel benzamide derivative having a structure of formula 1 or pharmaceutically acceptable salts thereof, and a composition for prevention or treatment of pain or itching including the above material. The novel benzamide derivative and pharmaceutically acceptable salt thereof according to the present invention exhibit excellent pain-suppressive effect and, in particular, pain-suppressive effect in not only a neuropathic animal model but also other models such as a formalin model, and therefore, may be used in suppression of different pains such as nociceptive pain, chronic pain, etc.
11/13/14
20140336273
Anhydrous sodium carbonate having a low pore content
The present invention relates to a highly pure, anhydrous sodium carbonate having a low pore content for use in pharmaceutical formulations and in the foods industry. Furthermore, a novel process for the preparation of this sodium carbonate is provided..
11/13/14
20140336266
Method for administering an nmda receptor antagonist to a subject
Compositions and methods for administering memantine to a subject are provided. In particular, a solid pharmaceutical composition in a unit dosage form for once daily oral administration is provided.
11/13/14
20140336252
Novel compound as kcnq potassium channel agonist, preparation method therefor and use thereof
The present invention provides compounds having the structure represented by general formula i, pharmaceutically acceptable salts thereofagonist, preparation methods therefor and a use thereof in the preparation of a medicine for the treatment of nervous system diseases. The compounds or pharmaceutical compositions thereof can be used as the kcnq potassium channel agonist for treating nervous system diseases.
11/13/14
20140336249
2-alkyl-or-aryl-substituted tanshinone derivatives, and preparation method and application thereof
The present invention belongs to the field of natural medicine and pharmaceutical chemistry, and specifically relates to novel 2-alkyl- or 2-aromatic-substituted tanshinone i derivatives of formula (i) or a pharmaceutically acceptable salt thereof, to a process for the preparation of these compounds, compositions containing such compounds and their use in preparing antineoplastic medicaments. When z═r, said derivative is 2-alkyl-substituted tanshinone i; when z═ar, said derivative is 2-aryl-substituted tanshinone i; when z=het, said derivative is 2-heteroaryl- or 2-heterocyclyl-substituted tanshinone i..
11/13/14
20140336248
Therapeutic compositions and related methods of use
Aqueous compositions comprising salinomycin, or a pharmaceutically acceptable salt thereof, miscible organic solvents, and solubilizers and/or emulsifying agents are disclosed. The formulations disclosed herein are useful in the treatment of cancer, especially cancers associated with cancer stem cells or cancerous mesenchymal cells.
11/13/14
20140336247
Daidzein derivative, pharmaceutically acceptable salt and preparation method thereof, and pharmaceutical composition containing same
Disclosed is a daidzein derivative as represented by formula (i), or pharmaceutically acceptable salt thereof. Compared to the daidzein in the prior art, the daidzein derivative hydrochloride, in particular to the 7-o—n,n-diethyl-aminoacetyl daidzein hydrochloride, prepared by the daidzein derivative of the present invention, has better solubility and effect for treating cardiovascular diseases..
11/13/14
20140336229
Pharmaceutical composition for preventing or treating hyperlipidemia
Provided is a pharmaceutical composition for preventing or treating hyperlipidemia comprising (4s,5r)-5-[3,5-bis(trifluoromethyl)phenyl]-3-({2-[4-fluoro-2-methoxy-5-(propan-2-yl)phenyl]-5-(trifluoromethyl)phenyl}methyl)-4-methyl-1,3-oxazolidin-2-one or its pharmaceutically acceptable salt; and an angiotensin ii receptor blocker as active ingredients.. .
11/13/14
20140336228
Pharmaceutical composition for preventing or treating hypertriglyceridemia or hypertriglyceridemia-associated diseases
Provided is a pharmaceutical composition for preventing or treating hyperlipidemia comprising (4s,5r)-5-[3,5-bis(trifluoromethyl)phenyl]-3-({2-[4-fluoro-2-methoxy-5-(propan-2-yl)phenyl]-5-(trifluoromethyl)phenyl}methyl)-4-methyl-1,3-oxazolidin-2-one or its pharmaceutically acceptable salt; and a calcium channel blocker or a fibrate as active ingredients.. .
11/13/14
20140336224
Mineralocorticoid receptor antagonists
Compounds of the formula (i) as well as pharmaceutically acceptable salts thereof, that may be useful for treating aldosterone-mediated diseases are disclosed. Processes for preparing compounds of the formula (i), use of the compounds for the therapy and prophylaxis of the abovementioned diseases and for preparing pharmaceuticals for this purpose, and pharmaceutical compositions which comprise compounds of the formula (i) are disclosed..
11/13/14
20140336222
Substituted piperidines that increase p53 activity and the uses thereof
As described herein or a pharmaceutically acceptable salt, solvate or ester thereof. The compounds are useful as inhibitors of the hdm2 protein.
11/13/14
20140336220
Composition for preventing or treating obesity comprising rebamipide
The present disclosure relates to a composition and a health functional food for preventing or treating obesity comprising a rebamipide compound or its pharmaceutically acceptable salt as an active component. It is confirmed that when a rebamipide compound of the present disclosure is administered to a mouse model induced with obesity, it shows excellent effects of reducing weight, reducing adipocyte, and reducing a total cholesterol content in the body, as compared with a non-administered control group, and also, it shows an excellent effect of suppressing differentiation of cytotoxic th17 cells that generate and secrets inflammatory cytokine and an excellent effect of improving activity of regulatory t cells (treg) capable of suppressing a function of abnormally activated immune cells and controlling an inflammatory reaction.
11/13/14
20140336208
1,4,5,6-tetrahydro-pyrimidin-2-ylamine compounds
Wherein r1 to r9 are as described below, or to pharmaceutically acceptable salts thereof. These compounds are bace2 inhibitors and can be used as medicaments for the therapeutic and/or prophylactic treatment of diseases such as diabetes, particularly type 2 diabetes, and other metabolic disorders..
11/13/14
20140336203
Crystalline forms of a bruton's tyrosine kinase inhibitor
Described herein is the bruton's tyrosine kinase (btk) inhibitor 1-((r)-3-(4-amino-3-(4-phenoxyphenyl)-1h-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one, including crystalline forms, solvates and pharmaceutically acceptable salts thereof. Also disclosed are pharmaceutical compositions that include the btk inhibitor, as well as methods of using the btk inhibitor, alone or in combination with other therapeutic agents, for the treatment of autoimmune diseases or conditions, heteroimmune diseases or conditions, cancer, including lymphoma, and inflammatory diseases or conditions..
11/13/14
20140336200
Arylosulfonamides for the treatment of cns diseases
Arylsulphonamide derivatives of formula (i) and pharmaceutically acceptable salts thereof. The compounds may be useful for the treatment and/or prevention of disorders of the central nervous system..
11/13/14
20140336191
Quinolinyloxyphenylsulfonamides
The present invention relates to quinolinyloxyphenylsulfonamides and stereoisomeric forms, solvates, hydrates and/or pharmaceutically acceptable salts of these quinolinyloxyphenylsulfonamide compounds as well as pharmaceutical compositions containing at least one of these compounds together with at least one pharmaceutically acceptable carrier, excipient and/or diluent. Said quinolinyloxyphenylsulfonamides are useful for prophylaxsis, treatment and/or after-treatment of hyperproliferative disorders, such as cancer, tumors and particularly cancer metastases..
11/13/14
20140336188
N-substituted indenoisoquinolines and syntheses thereof
N-substituted indenoisoquinoline compounds, and pharmaceutical formulations of n-substituted indenoisoquinoline compounds are described. Also described are processes for preparing n-substituted indenoisoquinoline compounds.
11/13/14
20140336177
Inhibitors of the renal outer medullary potassium channel
And the pharmaceutically acceptable salts thereof, which are inhibitors of the romk (kir1.1) channel. The compounds act as diuretics and natriuretics and are valuable pharmaceutically active compounds for the therapy and prophylaxis of medical conditions including cardiovascular diseases such as hypertension and conditions resulting from excessive salt and water retention..
11/13/14
20140336176
Heteroaromatic compounds and their use as dopamine d1 ligands
And pharmaceutically acceptable salts thereof and n-oxides of the foregoing; processes for the preparation of; intermediates used in the preparation of; and compositions containing such compounds, salts or n-oxides, and their uses for treating d1-mediated (or d1-associated) disorders including, e.g., schizophrenia (e.g., its cognitive and negative symptoms), cognitive impairment (e.g., cognitive impairment associated with schizophrenia, ad, pd, or pharmacotherapy therapy), adhd, impulsivity, compulsive gambling, overeating, autism spectrum disorder, mci, age-related cognitive decline, dementia, rls, parkinson's disease, huntington's chorea, anxiety, depression, mdd, trd, and bipolar disorder.. .
11/13/14
20140336163
Methods of preserving injectable pharmaceutical compositions comprising a cyclodextrin and a hydrophobic drug
The invention relates to injectable pharmaceutical compositions, methods of use and formulation, wherein the compositions comprise: one or more water soluble complexes, each complex comprising a cyclodextrin or a cyclodextrin derivative and a hydrophobic drug; at least one preservative; and at least one co-solvent. The compositions are effectively preserved in accordance with the european pharmacopoeia 2011 test for efficacy of antimicrobial preservation, satisfying at least the b criteria as it applies to parenterals, and the united states pharmacopeia 2011 guidelines for antimicrobial effectiveness testing, satisfying the criteria for category 1 (injectable) products..
11/13/14
20140336161
Pharmaceutical formulations containing corticosteroids for topical administration
The potency of a topical corticosteroid in a pharmaceutical formulation is maintained even when the concentration of the corticosteroid is substantially reduced by providing the corticosteroid in a formulation containing a liquid oil component that includes a dicarboxylic acid ester and/or a monocarboxylic acid ester.. .
11/13/14
20140336154
Benzopyran and benzoxepin pi3k inhibitor compounds and methods of use
Benzopyran and benzoxepin compounds of formulas i and ii, and including stereoisomers, geometric isomers, tautomers, solvates, metabolites and pharmaceutically acceptable salts thereof, are useful for inhibiting lipid kinases including p110 alpha and other isoforms of pi3k, and for treating disorders such as cancer mediated by lipid kinases. Methods of using compounds of formulas i and ii for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed..
11/13/14
20140336153
Substituted pyridine derivatives as fabi inhibitors
The present invention provides substituted pyridine derivatives of formula (i), which may be therapeutically useful as as anti-bacterial agents, more particularly fabi inhibitors. Formula (i) in which r1 to r5 and l have the meanings given in the specification, and pharmaceutically acceptable salts thereof that are useful in the treatment and prevention in diseases or disorder, in particular their use in diseases or disorder where there is an advantage anti-bacterial agents, more particularly fabi inhibitors.
11/13/14
20140336148
Combinations of diacerein and non-steroidal inflammation drugs
The present invention relates to novel pharmaceutical combinations with synergistic action of diacerein or a pharmaceutically acceptable salt of diacerein and non-steroidal inflammatory drugs, having analgesic, anti-inflammatory, antipyretic, and osteoarthritis-treating activities.. .
11/13/14
20140336143
Treatment of ebv and khsv infection and associated abnormal cellular proliferation
A method and composition for the treatment, prevention and/or prophylaxis of a host, and in particular, a human, infected with epstein-barr virus (ebv), is provided that includes administering an effective amount of a 5-substituted uracil nucleoside or its pharmaceutically acceptable salt or prodrug, optionally in a pharmaceutically acceptable diluent or excipient.. .
11/13/14
20140336131
Methods for treating inflammation, autoimmune disorders and pain
Disclosed herein are methods of treating, reducing, or preventing a disease such as oral mucositis, gastric mucositis, or inflammatory fibrosis, comprising identifying a patient in need of treatment and administering a therapeutically effective amount of at least one cationic steroid antimicrobial (csa), or a pharmaceutically acceptable salt thereof. Kits comprising such compositions and instructions on such methods are also contemplated herein..
11/13/14
20140336109
Modulation of ghrelin levels and ghrelin/unacylated ghrelin ratio using unacylated ghrelin
A method and a composition for decreasing ghrelin levels and/or decreasing ghrelin/unacylated ghrelin ratio in a subject, the method comprising administering an effective amount of unacylated ghrelin, a fragment thereof, an analog thereof and/or pharmaceutically acceptable salts thereof to the subject wherein a reduction in ghrelin levels and/or a reduction in ghrelin/unacylated ghrelin ratio is beneficial to the subject. Also, use of ghrelin level and/or ghrelin/unacylated ghrelin ratio as biomarkers for determining a subject's likelihood of responding to and/or benefiting from administration of unacylated ghrelin..
11/13/14
20140336106
Tripeptide epoxy ketone protease inhibitors
And pharmaceutically acceptable salts and compositions including the same. The compounds and compositions provided herein may be used, for example, in the treatment of diseases including inflammation and neurodegenerative disease..
11/13/14
20140336020
Toning garment with integrated damper
Disclosed is a muscle toning garment with force dampening resistance elements, which may be fluid filled rotary dampers. The garment provides resistance training throughout an angular range of motion.
11/13/14
20140335755
Stuffed animal with storage pouch for plastic bags or the like
A storage pouch is adapted for use with an animal body comprising a trunk having a waist and a shoulder. The storage pouch comprises a generally tubular shape garment comprising a continuous fabric panel defining an interior storage space having a top end opening and a bottom end opening.
11/13/14
20140335177
Pharmaceutical composition
Oral pharmaceutical formulations containing ditosylate salts of 4-quinazolineamines are described as well as methods of using the same in the treatment of disorders characterized by aberrant erbb family ptk activity.. .
11/13/14
20140335175
Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof
An extended release tablet formulation comprising pramipexole or a pharmaceutically acceptable salt thereof in a matrix comprising at least one water swelling polymer other than pregelatinized starch.. .
11/13/14
20140335112
Novel double-stranded ribonucleic acids with rugged physico-chemical structure and highly specific biologic activity
A novel form of rugged dsrna with a unique composition and physical characteristics was identified with high specificity of binding to tlr3, which conveys an important range of therapeutic opportunities. Unlike the previous known antiviral ampligen® (poly i, poly c12,u) the new and improved form (poly i, poly c30,u) has a reduced tendency to form branched dsrna which results in increased bioactivity due to an increased ability to bind tlr3 receptor.
11/13/14
20140335080
Ester derivatives of androgen receptor modulators and methods for their use
Or a pharmaceutically acceptable salt, tautomer, or stereoisomer thereof, wherein r1, r2, r3, r4, r5, j1, j2, x, z, n1 and n2 are as defined herein, and wherein at least one of r1, r2 or r3 is an alkyl, alkenyl, aryl or aralkyl ester, are provided. Uses of such compounds for treatment of various indications, including prostate cancer, as well as methods of treatment involving such compounds are also provided..
11/13/14
20140335052
Combination therapy for treating hcv infection in an hcv-hiv coinfected patient population
The present invention relates to therapeutic combinations comprising (a) compound (1), or a pharmaceutically acceptable salt thereof, as herein described, (b) an interferon alfa and (c) ribavirin. Compound (1) is a selective and potent inhibitor of the hcv ns3 serine protease.
11/13/14
20140335048
7-benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(1h)-one, salts thereof and methods of using the same in combination therapy
Or a pharmaceutically acceptable salt thereof in combination with a second therapeutic agent, wherein the first therapeutic agent and the second therapeutic agent are administered either simultaneously or sequentially.. .


Popular terms: [SEARCH]



Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Arm for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Arm with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         


FreshNews promo



0.4446

4691

3 - 0 - 76